On the 19th, during trading hours, hair loss treatment-related stocks are rallying across the board, drawing concentrated attention from investors. This is interpreted as a result of improving investment sentiment across the overall pharmaceutical and biotech sectors, along with expectations for market growth driven by the increasing hair loss population both domestically and internationally.

As of the morning of that day, JW Pharmaceutical surged 18.64% from the previous trading day to trade at 2,450 won, leading the gainers. In particular, its trading volume exceeded 32 million shares, proving the market's keen interest. Chaperone also recorded a double-digit gain, rising 13.17% to 1,358 won. Withers Pharmaceutical and Hyundai Pharmaceutical also continued their upward trend, trading at 8,650 won, up 10.90%, and 8,940 won, up 5.18%, respectively.

The market analyzed that as the growth potential of the hair loss treatment market comes to the forefront, expectations for companies with related technologies and pipelines are stimulating investment sentiment.

Securities industry officials project that since the hair loss treatment market is steadily growing, the research and development (R&D) achievements and commercialization progress of related companies will be key variables in future stock price movements.

[※ This article was written with the assistance of AI. Investment decisions are the responsibility of the investor, and the content contained in this article may change depending on market conditions.]